GENOMIC medicine company Lucence Diagnostics unveiled a new blood test to detect cancer and plans to launch a clinical study for a different blood test that can detect multiple cancers early.

TOPLINE

IN the past year since Clearbridge Health was listed on the Singapore Exchange's Catalist board in Dec 2017, the healthcare group has been busy....

IN A BOLD move for venture capital firms in the region, Singapore's Venturecraft has merged with medtech startup Mirxes to form Ark Bio, a cancer detection company armed with a US$40 million...

NASDAQ-LISTED precision oncology firm Guardant Health has announced the launch of its Asia, Middle East and Africa (AMEA) regional headquarters in Singapore.

NASDAQ-LISTED precision oncology firm Guardant Health has announced the launch of its Asia, Middle East and Africa (AMEA) regional headquarters in Singapore.

  •